daxibotulinumtoxinA November 17, 2017 daxibotulinumtoxinA Trade Name Orphan Indication Cervical dystonia USA Market Approval USA USA Designation Date 2017-11-16 00:00:00 Sponsor Revance Therapeutics, Inc.;7555 Gateway Boulevard;Newark, California, 94560
